These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5762156)

  • 21. Warfarin resistance linked to enteral nutrition products.
    Howard PA; Hannaman KN
    J Am Diet Assoc; 1985 Jun; 85(6):713-5. PubMed ID: 3998343
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of warfarin anticoagulation on vitamin-K 1 metabolism in man.
    Shearer MJ; McBurney A; Barkhan P
    Br J Haematol; 1973 Apr; 24(4):471-9. PubMed ID: 4715142
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma vitamin K1 level is decreased in primary biliary cirrhosis.
    Kowdley KV; Emond MJ; Sadowski JA; Kaplan MM
    Am J Gastroenterol; 1997 Nov; 92(11):2059-61. PubMed ID: 9362192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin K activity of phylloquinone oxide.
    Bell RG; Matschiner JT
    Arch Biochem Biophys; 1970 Dec; 141(2):473-6. PubMed ID: 5497142
    [No Abstract]   [Full Text] [Related]  

  • 25. Multivitamin supplements may affect warfarin anticoagulation in susceptible patients.
    Kurnik D; Lubetsky A; Loebstein R; Almog S; Halkin H
    Ann Pharmacother; 2003 Nov; 37(11):1603-6. PubMed ID: 14565795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on vitamin K1 content of enteral products.
    Kutsop JJ
    Am J Hosp Pharm; 1984 Sep; 41(9):1762. PubMed ID: 6437219
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of the hypoprothrombinemic effect of warfarin (Coumadin) by Ensure Plus, a dietary supplement.
    Michaelson R; Kempin SJ; Navia B; Gold JW
    Clin Bull; 1980; 10(4):171-2. PubMed ID: 7214706
    [No Abstract]   [Full Text] [Related]  

  • 28. The dose-dependent effect of warfarin on vitamin K1 metabolism and clotting factor synthesis in the rabbit.
    Park BK; Leck JB; Breckenridge AM
    Biochem Pharmacol; 1980 Jun; 29(11):1601-2. PubMed ID: 7396990
    [No Abstract]   [Full Text] [Related]  

  • 29. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitamin K1 disposition and therapy of warfarin overdose.
    Bjornsson TD; Blaschke TF
    Lancet; 1978 Oct; 2(8094):846-7. PubMed ID: 81403
    [No Abstract]   [Full Text] [Related]  

  • 31. Hereditary resistance to coumarin anticoagulant drugs in man and rat.
    O'Reilly RA; Pool JG; Aggeler PM
    Ann N Y Acad Sci; 1968 Jul; 151(2):913-31. PubMed ID: 4189970
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel role for vitamin K1 in a tyrosine phosphorylation cascade during chick embryogenesis.
    Saxena SP; Fan T; Li M; Israels ED; Israels LG
    J Clin Invest; 1997 Feb; 99(4):602-7. PubMed ID: 9045861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human sources and absorption of vitamin K in relation to anticoagulation stability.
    Udall JA
    JAMA; 1965 Oct; 194(2):127-9. PubMed ID: 5897315
    [No Abstract]   [Full Text] [Related]  

  • 34. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K.
    Conly JM; Stein K; Worobetz L; Rutledge-Harding S
    Am J Gastroenterol; 1994 Jun; 89(6):915-23. PubMed ID: 8198105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary induced subclinical vitamin K deficiency in normal human subjects.
    Ferland G; Sadowski JA; O'Brien ME
    J Clin Invest; 1993 Apr; 91(4):1761-8. PubMed ID: 8473516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interindividual variability in sensitivity to warfarin--Nature or nurture?
    Loebstein R; Yonath H; Peleg D; Almog S; Rotenberg M; Lubetsky A; Roitelman J; Harats D; Halkin H; Ezra D
    Clin Pharmacol Ther; 2001 Aug; 70(2):159-64. PubMed ID: 11503010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in plasma warfarin levels and variations in steady-state prothrombin times.
    White RH; Zhou H; Romano P; Mungall D
    Clin Pharmacol Ther; 1995 Nov; 58(5):588-93. PubMed ID: 7586953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictability of the warfarin maintenance dosage based on the initial response.
    McGhee JR; Evans R; Wolfson PM; Dunlap S; Haspel L; Smith CR; Braunstein DB
    J Am Osteopath Assoc; 1981 Jan; 80(5):335-9. PubMed ID: 7462045
    [No Abstract]   [Full Text] [Related]  

  • 39. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin resistance caused by broccoli.
    Kempin SJ
    N Engl J Med; 1983 May; 308(20):1229-30. PubMed ID: 6843604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.